Skip to content

Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid

Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02398266
Enrollment
55
Registered
2015-03-25
Start date
2016-08-01
Completion date
2018-07-01
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Brief summary

The measurement of limb skeletal muscle perfusion and perfusion reserve during exercise is an approach that can assess the total impact of the complex pathophysiologic processes in patients with limb ischemia, particularly in those with diabetes in whom distal arterial disease and abnormal microvascular functional responses are common. This trial is designed to: (a) optimize methods for assessment of limb perfusion at rest and during stress using contrast-enhanced ultrasound (normal subjects) and a microbubble contrast agent that is able to provide non-linear signal without destruction at medium acoustic pressures, and (b) to test whether perfusion imaging provides incremental information on the severity of disease in patients with peripheral artery disease.

Interventions

DRUGContrast ultrasound of leg muscle with Sonazoid (Contrast ultrasound microvascular perfusion imaging)

Skeletal muscle perfusion assessment of the thigh and calf skeletal muscle will be performed with contrast ultrasound of leg muscle with Sonazoid while at rest and during exercise stress

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* For Healthy controls: no active major medical problems or vasoactive medications * For PAD: Known diagnosis with PAD an ABI of 0.4-0.6

Exclusion criteria

* Rutherford class 6 or greater * Allergy to ultrasound contrast agents * Previous limb amputation * Pregnancy * Known congenital or acquired right to left shunt

Design outcomes

Primary

MeasureTime frame
Skeletal muscle perfusion as measured by contrast ultrasound with Sonazoid microbubbles5 minutes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026